IP Library Granted Patent US 12,509,734
Granted Patent B2
US 12,509,734 · App. 17/505,479 · Granted Dec 30, 2025

Systems and methods to assess microbiomes and treatments thereof

Inventors: Robert A. Akins (Novi, MI); Jack D. Sobel (West Bloomfield, MI)
Assignee: Wayne State University
C12Q1/689C12Q1/6883G16H10/40G16H20/10C12Q2600/106C12Q2600/158Y02A90/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,509,734
App. No.
17/505,479
Granted
Dec 30, 2025
Kind
B2
Abstract

Systems and methods to assess the health of various microbiomes and to identity species therein are disclosed. Described assessments and identifications can inform treatment decisions if a microbiome is determined to have a less than optimal balance of bacterial species within it; the presence of one or more negative species; and/or the absence of one or more positive species.

Claims (10)

1 . A kit for assessing health of a vaginal microbiome comprising:

a first set of primers comprising forward primers and reverse primers that support amplification of total bacterial DNA present in the vaginal microbiome, wherein at least one forward primer in the first set of primers comprises one of SEQ ID NO: 12, SEQ ID NO: 15, or one of any of SEQ ID NOs: 24-57, and at least one reverse primer in the first set of primers comprises one of SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 16, or one of any of SEQ ID NOs: 61-87; and

a second set of primers comprising at least one forward blocking primer and at least one reverse blocking primer, wherein the at least one forward blocking primer in the second set of primers partially overlaps the binding site of a forward primer in the first set of primers, wherein the at least one reverse blocking primer in the second set of primers partially overlaps the binding site of a reverse primer in the first set of primers, wherein the 3′ end of each of the at least one forward blocking primer and the at least one reverse blocking primer in the second set of primers comprises mismatches to sequences in the Lactobacillus (LB) genome, and wherein the kit is capable of detecting one or more non-LB species DNA at a titer below 1×10 6 cells/sample in an amplification reaction.

2 . The kit of claim 1 , wherein the melting temperatures of the forward and reverse blocking primers are at least 68° C.

3 . The kit of claim 1 , wherein the blocking primers are selected from LBblocker3 (SEQ ID NO: 22), LBB3p (SEQ ID NO: 23), LBblocker4 (SEQ ID NO: 59), and LBB4p (SEQ ID NO: 60).

4 . The kit of claim 1 , comprising primers selected from:

27F (SEQ ID NO: 12) and 338R (SEQ ID NO: 13);

338F (SEQ ID NO: 15) and 806R (SEQ ID NO: 16);

338F (SEQ ID NO: 15) and 338R (SEQ ID NO: 13); and/or

806R (SEQ ID NO: 28) and BU6 (SEQ ID NO: 58).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2021
From: AKINS, ROBERT A.; SOBEL, JACK D.
To: WAYNE STATE UNIVERSITY
Reel/Frame 057948/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2021
From: AKINS, ROBERT A.; SOBEL, JACK D.
To: WAYNE STATE UNIVERSITY
Reel/Frame 057948/0515 →
Continuity (5)
Continuation 16376796 · Apr 5, 2019
Continuation 14782449
Provisional Application 61840300 · Jun 27, 2013
Provisional Application 61809071 · Apr 5, 2013
Related Publication 20220049290A1 · Feb 17, 2022
References Cited (19)
US 5849497A · Steinman · 1998 [cited by applicant]
US 10253377B2 · Akins · 2019 [cited by examiner]
US 20040072242A1 · Hunter et al. · 2004 [cited by applicant]
US 20040111221A1 · Beattie et al. · 2004 [cited by applicant]
US 20060172330A1 · Osborn et al. · 2006 [cited by applicant]
US 20070178495A1 · Fredricks et al. · 2007 [cited by applicant]
US 20110151462A1 · Tynan et al. · 2011 [cited by applicant]
US 20120264126A1 · Johnson et al. · 2012 [cited by applicant]
US 20160040216A1 · Akins et al. · 2016 [cited by applicant]
US 20190264263A1 · Akins et al. · 2019 [cited by applicant]
WO WO2012151560A2 · 2012 [cited by applicant]
WO WO2014165810A2 · 2014 [cited by applicant]
Cheng, et al., “Rapid Detection and Identification of Clinically Important Bacteria by High-Resolution Melting Analysis after Broad-Range Ribosomal RNA Real-Time PCR”, Clinical Chemistry, vol. 52, No. 11, 2006, pp. 1997… [cited by applicant]
Gajer, et al., “Temporal Dynamics of the Human Vaginal Microbiota”, Science Translational Medicine, vol. 4, No. 132, 2012, pp. 1-13. [cited by applicant]
GenBank AY823501.3 “Lactobacillus Reuteri Strain 3S7 16S Ribosomal RNA Gene, partial sequence”, 2007, 2 pages. [cited by applicant]
GenBank JQ962733.2 “Uncultured [cited by applicant]
Lambert, et al., “Longitudinal Analysis of Vaginal Microbiome Dynamics in Women with Recurrent Bacterial Vaginosis: Recognition of the Converion Process”, PLOS One, vol. 8, No. 12, 2013, pp. 1-10. [cited by applicant]
Lambert, et al., “Novel PCR-Based Methods Enhance Characterization of Vaginal Microbiota in a Bacterial Vaginosis Patient Before and After Treatment”, Applied and Environmental Microbiology, vol. 79, No. 13, 2013, pp. 4… [cited by applicant]
Wintzingerode, et al, “Peptide Nucleic Acid-Mediated PCR Clamping as a Useful Supplement in the Determination of Microbial Diversity”, Applied and Environmental Microbiology, American Society for Microbiology, vol. 66, … [cited by applicant]